Friday, July 10, 2026

pharma · Esophageal Cancer · Esophageal Squamous Cell Carcinoma

Shanghai SIMR Biotech

Shanghai SIMR Biotech trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Shanghai, CN HQ
2014 Founded
23 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Shanghai, CN
Founded
2014
Employees
23
Programs
3
Drugs
14
Patents
0
Intelligence · Clinical Trials

Shanghai SIMR Biotech clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to Shanghai SIMR Biotech programs — each row shows trial ID, program name, phase, status, and indication.

Shanghai SIMR Biotech trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for Shanghai SIMR Biotech.

  1. SCHLC007 — Phase 2

    Clinical update
  2. neoadjuvant anti-PD-1 — Phase 2

    Clinical update
  3. PD-1inhibitor — Phase 2

    Clinical update

Trial registry

3 studies